The U.S. Agency for International Development (USAID) submits this report to Congress pursuant to P.L. 110-293, the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Authorization Act of 2008, Section 302(d), which amended P.L. 87-195, the Foreign Assistance Act of 1961, to add Section 104B(g)

4 results

Annual Tuberculosis Report to Congress, FY 2023

Tuberculosis (TB) remains one of the world’s leading infectious disease killers. Despite being preventable, treatable, and curable, this ancient disease continues to kill more people each year than HIV and malaria combined. In 2022, 10.6 million people contracted TB, and 1.3 million lost their lives to the deadly disease.

Annual Tuberculosis Report to Congress, FY 2022

Nearly 30 years after the World Health Organization (WHO) declared tuberculosis (TB) a public health emergency, the disease remains one of the world’s leading infectious disease killers–claiming more lives each year than HIV and malaria combined. Until the emergence of COVID-19, the bacterium that causes TB was described as “the most destructive pathogen on the planet.” Despite being preventable, treatable, and curable, this ancient disease persists, resurges, and continues to take a global toll–particularly among the most vulnerable and poorest populations.

Annual Tuberculosis Report to Congress, FY 2021

The U.S. Agency for International Development (USAID) leads the U.S. Government’s global TB efforts by working with agencies and partners around the world on the shared goals of reaching every person with the disease, curing those in need of treatment, and preventing the spread of new infections and the progression to active TB disease.

Annual Tuberculosis Report to Congress, FY 2020

Tuberculosis (TB) is the world’s leading infectious-disease killer. In Calendar Year 2019, TB took the lives of an estimated 1.4 million—more than HIV and malaria combined— and sickened an estimated ten million people.